Assessing the Medicinal Uses of Psychedelics - Part 2

Assessing the Medicinal Uses of Psychedelics - Part 2

From NightSide With Dan Rea by WBZ-AM

May 1, 2026 · 24 min

About this episode

The episode discusses the medicinal uses of psychedelics and features Dr. Kristen Cherian's insights on the topic.

Continued conversation about how President Trump has signed an executive order designed to fast-track both research on and access to the medicinal use of psychedelic drugs, including a $50 million investment in state governments to study how psychedelics might help people struggling with mental health illnesses. Dr. Kristen Cherian, a researcher of psychedelic medicine at Stanford University, joined the program to answer questions, break down the pros and cons of psychedelic use, and discuss how drugs like ibogaine, which have not been approved by the FDA, have been used to decrease opioid cravings and treat severe depression, anxiety, and post-traumatic stress disorder symptoms in veterans.  See omnystudio.com/listener for privacy information.

People in this episode

Host: Dan Rea

Guest: Dr. Kristen Cherian

Topics covered

  • psychedelics
  • mental health
  • opioid cravings
  • depression
  • anxiety
  • PTSD
  • research

Keywords

  • psychedelics
  • medicinal use
  • mental health
  • opioid treatment
  • depression
  • anxiety
  • PTSD
  • research funding

Mentioned in this episode

Organizations: Stanford University

Products: ibogaine

More episodes of NightSide With Dan Rea

Explore listener stats, chart rankings, contacts and more on the NightSide With Dan Rea podcast page.